GlassScriptPhysician profile
Amanda L Storey
NPI 1295883031
$326.25
in general payments reported to CMS, 2019-2025
14 companies · $52.04 in 2025
The $52.04 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $33.69 · 2020: $20.48 · 2021: $50.98 · 2022: $91.46 · 2023: $45.35 · 2024: $32.25 · 2025: $52.04.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $130.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $129.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $60.22 | 2022-2024 | Mounjaro |
| Amgen INC. | $58.03 | 2020-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $36.38 | 2025 | |
| Sanofi-Aventis U.S. LLC | $26.21 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $18.54 | 2021 | |
| Novo Nordisk INC | $18.02 | 2024 | Ozempic, Rybelsus |
| Abbvie INC. | $16.69 | 2022 | |
| Exact Sciences Corporation | $15.66 | 2025 | The Cologuard Plus Collection Kit |
| Novartis Pharmaceuticals Corporation | $14.78 | 2022 | |
| Glaxosmithkline, LLC. | $14.21 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $13.82 | 2023 | Farxiga |
| Merck Sharp & Dohme LLC | $11.62 | 2019 | |
| Pfizer INC. | $11.06 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $11.01 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amanda Storey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.